144 related articles for article (PubMed ID: 20154547)
1. Recombinant factor VIIa for the correction of coagulopathy before emergent craniotomy in blunt trauma patients.
Brown CV; Foulkrod KH; Lopez D; Stokes J; Villareal J; Foarde K; Curry E; Coopwood B
J Trauma; 2010 Feb; 68(2):348-52. PubMed ID: 20154547
[TBL] [Abstract][Full Text] [Related]
2. Reversal of coagulopathy in critically ill patients with traumatic brain injury: recombinant factor VIIa is more cost-effective than plasma.
Stein DM; Dutton RP; Kramer ME; Scalea TM
J Trauma; 2009 Jan; 66(1):63-72; discussion 73-5. PubMed ID: 19131807
[TBL] [Abstract][Full Text] [Related]
3. The use of recombinant activated factor VIIa in coagulopathic traumatic brain injuries requiring emergent craniotomy: is it beneficial?
McQuay N; Cipolla J; Franges EZ; Thompson GE
J Neurosurg; 2009 Oct; 111(4):666-71. PubMed ID: 19425887
[TBL] [Abstract][Full Text] [Related]
4. Recombinant factor VIIa: decreasing time to intervention in coagulopathic patients with severe traumatic brain injury.
Stein DM; Dutton RP; Kramer ME; Handley C; Scalea TM
J Trauma; 2008 Mar; 64(3):620-7; discussion 627-8. PubMed ID: 18332801
[TBL] [Abstract][Full Text] [Related]
5. Use of recombinant factor VIIa in US military casualties for a five-year period.
Wade CE; Eastridge BJ; Jones JA; West SA; Spinella PC; Perkins JG; Dubick MA; Blackbourne LH; Holcomb JB
J Trauma; 2010 Aug; 69(2):353-9. PubMed ID: 20699744
[TBL] [Abstract][Full Text] [Related]
6. Early versus late recombinant factor VIIa in combat trauma patients requiring massive transfusion.
Perkins JG; Schreiber MA; Wade CE; Holcomb JB
J Trauma; 2007 May; 62(5):1095-9; discussion 1099-101. PubMed ID: 17495707
[TBL] [Abstract][Full Text] [Related]
7. Recombinant activated factor VII as an adjunctive therapy for bleeding control in severe trauma patients with coagulopathy: subgroup analysis from two randomized trials.
Rizoli SB; Boffard KD; Riou B; Warren B; Iau P; Kluger Y; Rossaint R; Tillinger M;
Crit Care; 2006; 10(6):R178. PubMed ID: 17184516
[TBL] [Abstract][Full Text] [Related]
8. Utilization of recombinant activated factor VII for intracranial hematoma evacuation in coagulopathic nonhemophilic neurosurgical patients with normal international normalized ratios.
McClelland S; Won EK; Lam CH
Neurocrit Care; 2007; 7(2):136-9. PubMed ID: 17846720
[TBL] [Abstract][Full Text] [Related]
9. Low-dose recombinant factor VIIa for trauma patients with coagulopathy.
Stein DM; Dutton RP; Hess JR; Scalea TM
Injury; 2008 Sep; 39(9):1054-61. PubMed ID: 18656871
[TBL] [Abstract][Full Text] [Related]
10. Administration off label of recombinant factor-VIIa (rFVIIa) to patients with blunt or penetrating brain injury without coagulopathy.
Zaaroor M; Soustiel JF; Brenner B; Bar-Lavie Y; Martinowitz U; Levi L
Acta Neurochir (Wien); 2008 Jul; 150(7):663-8. PubMed ID: 18473114
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of factor VIIa in emergency department patients with warfarin use and traumatic intracranial hemorrhage.
Nishijima DK; Dager WE; Schrot RJ; Holmes JF
Acad Emerg Med; 2010 Mar; 17(3):244-51. PubMed ID: 20370756
[TBL] [Abstract][Full Text] [Related]
12. The clinical and laboratory response to recombinant factor VIIA in trauma and surgical patients with acquired coagulopathy.
McMullin NR; Kauvar DS; Currier HM; Baskin TW; Pusateri AE; Holcomb JB
Curr Surg; 2006; 63(4):246-51. PubMed ID: 16843774
[TBL] [Abstract][Full Text] [Related]
13. Recombinant activated factor VII for the rapid correction of coagulopathy in nonhemophilic neurosurgical patients.
Park P; Fewel ME; Garton HJ; Thompson BG; Hoff JT
Neurosurgery; 2003 Jul; 53(1):34-8; discussion 38-9. PubMed ID: 12823871
[TBL] [Abstract][Full Text] [Related]
14. "Low-dose" recombinant activated factor VII results in less blood and blood product use in traumatic hemorrhage.
Harrison TD; Laskosky J; Jazaeri O; Pasquale MD; Cipolle M
J Trauma; 2005 Jul; 59(1):150-4. PubMed ID: 16096555
[TBL] [Abstract][Full Text] [Related]
15. Effects of recombinant activated factor VII in traumatic nonsurgical intracranial hemorrhage.
White CE; Schrank AE; Baskin TW; Holcomb JB
Curr Surg; 2006; 63(5):310-7. PubMed ID: 16971200
[TBL] [Abstract][Full Text] [Related]
16. Recombinant activated coagulation factor VII and bleeding trauma patients.
Rizoli SB; Nascimento B; Osman F; Netto FS; Kiss A; Callum J; Brenneman FD; Tremblay L; Tien HC
J Trauma; 2006 Dec; 61(6):1419-25. PubMed ID: 17159685
[TBL] [Abstract][Full Text] [Related]
17. Recombinant coagulation factor VIIa for rapid preoperative correction of warfarin-related coagulopathy in patients with acute subdural hematoma.
Veshchev I; Elran H; Salame K
Med Sci Monit; 2002 Dec; 8(12):CS98-100. PubMed ID: 12503044
[TBL] [Abstract][Full Text] [Related]
18. Recombinant activated factor VII for coagulopathy in fulminant hepatic failure compared with conventional therapy.
Shami VM; Caldwell SH; Hespenheide EE; Arseneau KO; Bickston SJ; Macik BG
Liver Transpl; 2003 Feb; 9(2):138-43. PubMed ID: 12548507
[TBL] [Abstract][Full Text] [Related]
19. Coagulopathic patients with traumatic intracranial bleeding: defining the role of recombinant factor VIIa.
Bartal C; Freedman J; Bowman K; Cusimano M
J Trauma; 2007 Oct; 63(4):725-32. PubMed ID: 18089997
[TBL] [Abstract][Full Text] [Related]
20. Prothrombin complex concentrate versus recombinant factor VIIa for reversal of hemodilutional coagulopathy in a porcine trauma model.
Dickneite G; Dörr B; Kaspereit F; Tanaka KA
J Trauma; 2010 May; 68(5):1151-7. PubMed ID: 19996804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
